简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2016-03-07 11:21 Oral OTEZLA® (apremilast) Data from Open-Label Phase of ESTEEM and LIBERATE™ Trials to Be Presented at American Academy of Dermatology Congress
2016-03-04 16:23 GORE® EXCLUDER® Iliac Branch Endoprosthesis Gains FDA Approval
2016-03-02 17:10 ReSound® Introduces the World’s Smartest Super Power Hearing Aid
2016-03-02 15:26 Alexion Employees Across the Globe Join Together to Support Rare Disease Day 2016
2016-03-02 13:28 Mitsubishi Tanabe Pharma Corporation Signs Licensing Agreement with A. Menarini Asia-Pacific for Spedra (Avanafil) in 10 Countries in Asia-Pacific
2016-03-01 10:25 European Committee for Medicinal Products for Human Use recommends approval of Giotrif® (afatinib) for advanced squamous cell cancer of the lung
2016-02-29 16:51 New survey gives voice to people living with a rare and devastating lung disease: “When I think of IPF I think of breathlessness”
2016-02-26 17:29 Manipal Hospitals is the First in India to Adopt Masimo Patient SafetyNet™
2016-02-26 09:56 New analysis confirms OFEV® (nintedanib) slows disease progression in IPF and reduces risk of acute exacerbations
2016-02-24 17:22 Quintiles Named to Fortune Magazine's 2016 List of “World’s Most Admired Companies”
2016-02-24 10:25 Primex Pharmaceuticals: New Acquisition Brings an Innovative Oral Solution for Pediatric Anesthesiology to the Market
2016-02-23 10:41 So Smart, It’s GENIUS – Oral-B Unveils the World’s First Electric Toothbrush that Sees What You Don’t
2016-02-23 09:59 InFo Instant Focus© – A Revolution in Natural Lens Surgery for Cataract
2016-02-22 17:58 Kurt Salmon Announces New Global Leadership
2016-02-22 14:03 Australian Expert in Sports Science and Nutrition Joins Herbalife Nutrition Advisory Board
2016-02-19 10:09 Oral Ozanimod 72-Week Phase 2 Results From RADIANCE Trial in Relapsing Multiple Sclerosis Presented At ACTRIMS
2016-02-18 15:15 SAB Biotherapeutics Produces New Human Antibody Treatment for MERS-CoV
2016-02-18 10:21 GORE® EXCLUDER® Device Reaches Significant Milestone
2016-02-18 10:03 Replicor to Present Pre-Clinical and Updated Clinical Data on REP 2139-Ca Based Combination Therapy in Chronic HBV and HBV / HDV Co-Infection at APASL 2016
2016-02-17 17:40 CiteAb Names Cell Signaling Technology, “Antibody Company of the Year” and “Researchers’ Choice”

Business Wire Weibo

Press Releases

Latest Releases